Daxor Revenue 2010-2011 | DXR

Daxor revenue from 2010 to 2011. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
Daxor Annual Revenue
(Millions of US $)
2011 $1
2010 $2
2009 $2
Daxor Quarterly Revenue
(Millions of US $)
2011-12-31 $0
2011-09-30 $0
2011-06-30 $0
2011-03-31 $0
2010-12-31 $0
2010-09-30 $0
2010-06-30 $0
2010-03-31 $0
2009-12-31 $0
2009-09-30 $0
2009-06-30 $0
2009-03-31 $0
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $0.046B $0.000B
Daxor Corporation is a medical device manufacturing corporation with additional biotech services.
Stock Name Country Market Cap PE Ratio
Quest Diagnostics (DGX) United States $19.382B 19.10
Encompass Health (EHC) United States $11.869B 25.16
DaVita (DVA) United States $10.709B 15.06
Elanco Animal Health (ELAN) United States $7.340B 15.72
Chemed (CHE) United States $6.899B 21.68
Option Care Health (OPCH) United States $5.017B 22.36
RadNet (RDNT) United States $4.323B 274.38
Amedisys (AMED) United States $3.213B 21.61
Addus HomeCare (ADUS) United States $2.105B 23.11
LifeStance Health (LFST) United States $1.847B 0.00
Astrana Health (ASTH) United States $1.391B 34.47
U.S Physical Therapy (USPH) United States $1.162B 29.99
Pennant (PNTG) United States $0.902B 33.11
Aveanna Healthcare Holdings (AVAH) United States $0.833B 47.44
Atai Life Sciences (ATAI) Germany $0.533B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.040B 0.00
Ontrak (OTRK) United States $0.002B 0.00
Psychemedics (PMD) United States $0.000B 0.00